Abstract
Fluorescence spectroscopy Excitation Emission Matrix (EEM) measurements were applied on human blood plasma samples from a case control study on colorectal cancer. Samples were collected before large bowel endoscopy and included patients with colorectal cancer or with adenomas, and from individuals with other non malignant findings or no findings (N = 308). The objective of the study was to explore the possibilities for applying fluorescence spectroscopy as a tool for detection of colorectal cancer. Parallel Factor Analysis (PARAFAC) was applied to decompose the fluorescence EEMs into estimates of the underlying fluorophores in the sample. Both the pooled score matrix from PARAFAC, holding the relative concentrations of the derived components, and the raw unfolded spectra were used as basis for discrimination models between cancer and the various controls. Both methods gave test set validated sensitivity and specificity values around 0.75 between cancer and controls, and poor discriminations between the various controls. The PARAFAC solution gave better options for analyzing the chemical mechanisms behind the discrimination, and revealed a blue shift in tryptophan emission in the cancer patients, a result that supports previous findings. The present findings show how fluorescence spectroscopy and chemometrics can help in cancer diagnostics, and with PARAFAC fluorescence spectroscopy can be a potential metabonomic tool.
Similar content being viewed by others
References
Abugo, O. O., Nair, R., & Lakowicz, J. R. (2000). Fluorescence properties of rhodamine 800 in whole blood and plasma. Analytical Biochemistry, 279, 142–150.
Andersen, C. M., & Bro, R. (2003). Practical aspects of PARAFAC modeling of fluorescence excitation-emission data 1. Journal of Chemometrics, 17, 200–215.
Bro, R. (1997). PARAFAC. Tutorial and applications 1. Chemometrics and Intelligent Laboratory Systems, 38, 149–171.
DeRose, P. C., & Resch-Genger, U. (2010). Recommendations for fluorescence instrument qualification: The new ASTM standard guide. Analytical Chemistry, 82, 2129–2133.
Flamini, E., Mercatali, L., Nanni, O., Calistri, D., Nunziatini, R., Zoli, W., et al. (2006). Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer. Clinical Cancer Research, 12, 6985–6988.
Hamdan, M. H. (2007). Cancer biomarkers. Hoboken: John Wiley and sons.
Harshman, R. A., & DeSarbo, W. S. (1984). An application of PARAFAC to a small sample problem, demonstrating preprocessing, orthogonality constraints, and split-half diagnostic techniques. In H. G. Law, et al. (Eds.), Research methods for multimode data analysis (pp. 602–642). New York: Praeger.
Hubmann, M. R., Leiner, M. J. P., & Schaur, R. J. (1990). Ultraviolet fluorescence of human sera.1. Sources of characteristic differences in the ultraviolet fluorescence-spectra of sera from normal and cancer-bearing humans 1. Clinical Chemistry, 36, 1880–1883.
Jackson, J. E. (1991). Operations with group data. Hoboken: John Wiley & Sons, Inc.
Jenkinson, F., & Steele, R. J. C. (2010). Colorectal cancer screening—methodology. Surgeon-Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 8, 164–171.
Kalaivani, R., Masilamani, V., Sivaji, K., Elangovan, M., Selvaraj, V., Balamurugan, S. G., et al. (2008). Fluorescence spectra of blood components for breast cancer diagnosis. Photomedicine and Laser Surgery, 26, 251–256.
Lakowicz, J. R. (2006). Principles of Fluorescence Spectroscopy. New York: Springer.
Lawaetz, A. J., & Stedmon, C. A. (2009). Fluorescence intensity calibration using the Raman scatter peak of water. Applied Spectroscopy, 63, 936–940.
Leiner, M. J., Schaur, R. J., Desoye, G., & Wolfbeis, O. S. (1986). Fluorescence topography in biology. III: Characteristic deviations of tryptophan fluorescence in sera of patients with gynecological tumors. Clinical Chemistry, 32, 1974–1978.
Leiner, M., Schaur, R. J., Wolfbeis, O. S., & Tillian, H. M. (1983). Fluorescence topography in biology. 2. Visible fluorescence topograms of rat sera and cluster-analysis of fluorescence parameters of sera of Yoshida ascites hepatoma-bearing rats. IRCS Medical Science-Biochemistry, 11, 841–842.
Lomholt, A. F., Hoyer-Hansen, G., Nielsen, H. J., & Christensen, I. J. (2009). Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer. British Journal of Cancer, 101, 992–997.
Madhuri, S., Aruna, P., Summiya Bibi, M. I., Gowri, V. S., Koteeswaran, D., Schaur, R. J., et al. (1997). Ultraviolet fluorescence spectroscopy of blood plasma in the discrimination of cancer from normal. Proceedings of SPIE, 2982, 41–45.
Madhuri, S., Suchitra, S., Aruna, P., Srinivasan, T. G., & Ganesan, S. (1999). Native fluorescence characteristics of blood plasma of normal and liver diseased subjects. Medical Science Research, 27, 635–639.
Madhuri, S., Vengadesan, N., Aruna, P., Koteeswaran, D., Venkatesan, P., & Ganesan, S. (2003). Native fluorescence spectroscopy of blood plasma in the characterization of oral malignancy. Photochemistry and Photobiology, 78, 197–204.
Masilamani, V., Al-Zhrani, K., Al-Salhi, M., Al-Diab, A., & Al-Ageily, M. (2004). Cancer diagnosis by autofluorescence of blood components. Journal of Luminescence, 109, 143–154.
McKnight, D. M., Boyer, E. W., Westerhoff, P. K., Doran, P. T., Kulbe, T., & Andersen, D. T. (2001). Spectrofluorometric characterization of dissolved organic matter for indication of precursor organic material and aromaticity. Limnology and Oceanography, 46, 38–48.
Nielsen, H. J., Brunner, N., Frederiksen, C., Lomholt, A. F., King, D., Jorgensen, L. N., et al. (2008). Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection. Scandinavian Journal of Gastroenterology, 43, 242–248.
Nordström, A., & Lewensohn, R. (2010). Metabolomics: Moving to the Clinic. Journal of Neuroimmune Pharmacology, 5, 4–17.
Nørgaard, L., Saudland, A., Wagner, J., Nielsen, J. P., Munck, L., & Engelsen, S. B. (2000). Interval partial least-squares regression (iPLS): A comparative chemometric study with an example from near-infrared spectroscopy. Applied Spectroscopy, 54, 413–419.
Nørgaard, L., Soletormos, G., Harrit, N., Albrechtsen, M., Olsen, O., Nielsen, D., et al. (2007). Fluorescence spectroscopy and chemometrics for classification of breast cancer samples—a feasibility study using extended canonical variates analysis. Journal of Chemometrics, 21, 451–458.
Ragazzi, E., Pucciarelli, S., Seraglia, R., Molin, L., Agostini, M., Lise, M., et al. (2006). Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. Journal of Mass Spectrometry, 41, 1546–1553.
The Danish Cancer Society. (2010). http://www.cancer.dk.
The Danish National Board of Health. (2010). National screening for tyk- og endetarmskræft. The Danish National Board of Health, 1.
Uppal, A., Ghosh, N., Datta, A., & Gupta, P. K. (2005). Fluorimetric estimation of the concentration of NADH from human blood samples 1. Biotechnology and Applied Biochemistry, 41, 43–47.
Vivian, J. T., & Callis, P. R. (2001). Mechanisms of tryptophan fluorescence shifts in proteins. Biophysical Journal, 80, 2093–2109.
Ward, D. G., Suggett, N., Cheng, Y., Wei, W., Johnson, H., Billingham, L. J., et al. (2006). Identification of serum biomarkers for colon cancer by proteomic analysis. British Journal of Cancer, 94, 1898–1905.
Wold, S., Sjostrom, M., & Eriksson, L. (2001). PLS-regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems, 58, 109–130.
Wolfbeis, O. S., & Leiner, M. (1985). Mapping of the total fluorescence of human-blood serum as a new method for its characterization. Analytica Chimica Acta, 167, 203–215.
Xu, X. R., Meng, J. W., Hou, S. G., Ma, H. P., & Wang, D. S. (1988). The characteristic fluorescence of the serum of cancer-patients. Journal of Luminescence, 40–1, 219–220.
Zhang, Xuewu, Li, Lin, Wei, Dong, Yap, Yeeleng, & Chen, Feng. (2007). Moving cancer diagnostics from bench to bedside. Trends in Biotechnology, 25, 166–173.
Zhao, Z., Xiao, Y., Elson, P., Tan, H., Plummer, S. J., Berk, M., et al. (2007). Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer. Journal of Clinical Oncology, 25, 2696–2701.
Acknowledgments
The VILLUM FOUNDATION is thanked for funding Anders Juul Lawaetz. Abdelrhani Mourhib is thanked for his laboratory assistance. Knud Nielsen, Randers Hospital, Søren Laurberg, Aarhus Hospital, Jesper Olsen, Glostrup Hospital and Hans B Rahr, Odense Hospital, are acknowledged for their contribution to the original protocol.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lawaetz, A.J., Bro, R., Kamstrup-Nielsen, M. et al. Fluorescence spectroscopy as a potential metabonomic tool for early detection of colorectal cancer. Metabolomics 8 (Suppl 1), 111–121 (2012). https://doi.org/10.1007/s11306-011-0310-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-011-0310-7